NATURECELL CO.,LTD. Logo

NATURECELL CO.,LTD.

Biotech company developing stem cell therapies, food, beverages, and cosmetics.

007390 | KO

Overview

Corporate Details

ISIN(s):
KR7007390008
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 국회대로76길 10 5층, 서울특별시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

NATURECELL CO.,LTD. is a South Korean biotechnology company with diversified operations across three primary segments: stem cell research, food and beverages, and cosmetics. The company's high-tech bio division focuses on the research and development of stem cell-based therapies for degenerative diseases. In the consumer goods sector, Naturecell manufactures and sells a range of products including canned goods, fruit juices, and health-functional foods. It also develops and markets cosmetics, often leveraging its biotechnological expertise.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 00:00
Report Publication Announcement
[기재정정]기업설명회(IR)개최
Korean 10.7 KB
2025-09-08 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.0 KB
2025-09-08 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 9.0 KB
2025-08-21 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.3 KB
2025-08-19 00:00
Legal Proceedings Report
[기재정정]기타주요경영사항 (조인트스템 판매계약 유지 결정)
Korean 12.6 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.8 MB
2025-08-06 00:00
Regulatory News Service
[기재정정]기타주요경영사항 (조인트스템 국내 품목허가 결과 통지)
Korean 12.9 KB
2025-05-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 156.0 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-05-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 25.0 KB
2025-03-26 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 29.1 KB
2025-03-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 155.2 KB
2025-03-26 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등거래계획보고서
Korean 47.5 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 25.3 KB

Automate Your Workflow. Get a real-time feed of all NATURECELL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NATURECELL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NATURECELL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan
4564

Talk to a Data Expert

Have a question? We'll get back to you promptly.